Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinoma Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05993429
What this trial is testing

Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma

Who this might be right for
Klatskin TumorCholangiocarcinomaBiopsy, Fine-Needle+1 more
Qilu Hospital of Shandong University 200
Early research (Phase 1)UnknownNCT06081322
What this trial is testing

Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors

Who this might be right for
Advanced Pancreatic Cancer and Cholangiocarcinoma
Zhejiang University 29
Testing effectiveness (Phase 2)Study completedNCT00084942
What this trial is testing

Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
Roswell Park Cancer Institute
Not applicableNot Yet RecruitingNCT07716345
What this trial is testing

Inter-Individual Tumor Heterogeneity on 3D-MRE for Predicting Response to Conversion Therapy in Liver Cancer

Who this might be right for
Hepato Cellular CarcinomaIntrahepatic Bile Duct CarcinomaMetastatic Hepatocellular Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07561775
What this trial is testing

Adebrelimab Plus S-1 for Resected Cholangiocarcinoma

Who this might be right for
CholangiocarcinomaBiliary Tract Cancer
Xingjun Guo 40
Testing effectiveness (Phase 2)Study completedNCT00003557
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
University of Chicago 16
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Not applicableUnknownNCT02958059
What this trial is testing

Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient

Who this might be right for
Biliary Obstructive Disease Such as CholedocholithiasisBenign Biliary StricturePeri-ampullary Cancer+2 more
Yonsei University 400
Early research (Phase 1)Ended earlyNCT02757391
What this trial is testing

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more
M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT03027284
What this trial is testing

Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer

Who this might be right for
Advanced CancerMetastatic CancerBiliary Tract Carcinoma+4 more
Eli Lilly and Company 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT05174650
What this trial is testing

Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 Fusions/Rearrangements

Who this might be right for
Intrahepatic Cholangiocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 27
Large-scale testing (Phase 3)Study completedNCT00304135
What this trial is testing

Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Federation Francophone de Cancerologie Digestive 34
Testing effectiveness (Phase 2)Study completedNCT01206049
What this trial is testing

Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations

Who this might be right for
Cholangiocarcinoma
Vejle Hospital 88
Not applicableUnknownNCT02588755
What this trial is testing

TACE Plus Tegafur Versus TACE for Intrahepatic Cholangiocarcinoma After Curative Resection

Who this might be right for
Intrahepatic Cholangiocarcinoma
Eastern Hepatobiliary Surgery Hospital 180
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Looking for participantsNCT05678270
What this trial is testing

ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (ICC)
Beijing InnoCare Pharma Tech Co., Ltd. 70
Not applicableUnknownNCT01914289
What this trial is testing

Prognosis of Resection and Radiotherapy in the Treatment of Intrahepatic Cholangiocarcinoma Patients

Who this might be right for
Intrahepatic Cholangiocarcinoma
Eastern Hepatobiliary Surgery Hospital 200
Not applicableApproved For MarketingNCT04507503
What this trial is testing

Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

Who this might be right for
Advanced Cholangiocarcinoma
Taiho Oncology, Inc.
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Not applicableNot Yet RecruitingNCT07704216
What this trial is testing

Peritumoral MRE Stiffness for Predicting Resection Margin Status and Recurrence in Liver Cancer

Who this might be right for
Hepato Cellular CarcinomaIntrahepatic Bile Duct CarcinomaMetastatic Hepatocellular Carcinoma
Second Affiliated Hospital of Xi'an Jiaotong University 150
Next Page